Silence Therapeutics (ADR) (SLN)
Develops liver-targeted siRNA medicines through its mRNAi GOLD platform.
$12.29
After hours0.00 (0.00%)
At close$12.29(+0.33%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
−$0.12
Revenue estimate
$124.2K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.27−$0.60−$0.54−$0.45−$0.25−$0.32−$0.26Pending
Estimate−$0.45−$0.18−$0.27−$0.40−$0.32−$0.33−$0.13−$0.12
Surprise+160.0%−233.3%−100.0%−12.5%+21.9%+3.0%−104.4%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$25.1M$142.0K$224.0K$159.0K$39.0K$422.0K$137.2KPending
Estimate$6.8M$5.2M$7.0M$4.4M$2.9M$1.3M$1.1M$124.2K
Surprise+270.5%−97.3%−96.8%−96.4%−98.7%−66.4%−87.9%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.10 | — | — |
| Sep 2028 | −$0.10 | — | — |
| Jun 2028 | −$0.10 | — | — |
| Mar 2028 | −$0.10 | — | — |
| Dec 2027 | −$0.14 | — | — |
| Sep 2027 | −$0.13 | — | — |
| Jun 2027 | −$0.15 | — | — |
| Mar 2027 | −$0.13 | — | — |
| Dec 2026 | −$0.12 | — | — |
| Nov 2026 | −$0.12 | — | — |
| Aug 2026 | −$0.13 | −$0.26 | −104.4% |
| May 2026 | −$0.33 | −$0.32 | +3.0% |
| Mar 2026 | −$0.32 | −$0.25 | +21.9% |
| Nov 2025 | −$0.40 | −$0.45 | −12.5% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | −$0.32 | — | — |
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Mar 2015 | |||
| Dec 2014 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.10 | — | — | $165.8K | — | — | — |
| Sep 2028 | −$0.10 | — | — | $148.1K | — | — | — |
| Jun 2028 | −$0.10 | — | — | $155.9K | — | — | — |
| Mar 2028 | −$0.10 | — | — | $164.1K | — | — | — |
| Dec 2027 | −$0.14 | — | — | $1.7M | — | — | — |
| Sep 2027 | −$0.13 | — | — | $1.7M | — | — | — |
| Jun 2027 | −$0.15 | — | — | $1.4M | — | — | — |
| Mar 2027 | −$0.13 | — | — | $1.2M | — | — | — |
| Dec 2026 | −$0.12 | — | — | $102.7K | — | — | — |
| Nov 5, 2026 | −$0.12 | — | — | $124.2K | — | — | — |
| Aug 10, 2026 | −$0.13 | −$0.26 | −104.4% | $1.1M | $137.2K | −87.9% | +29.1% |
| May 7, 2026 | −$0.33 | −$0.32 | +3.0% | $1.3M | $422.0K | −66.4% | −5.6% |
| Mar 5, 2026 | −$0.32 | −$0.25 | +21.9% | $2.9M | $39.0K | −98.7% | −4.8% |
| Nov 6, 2025 | −$0.40 | −$0.45 | −12.5% | $4.4M | $159.0K | −96.4% | +3.4% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 15, 2024 | −$0.32 | — | — | $11.8M | — | — | — |
| May 16, 2024 | |||||||
| Mar 13, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 16, 2023 | |||||||
| May 16, 2023 | |||||||
| Mar 15, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 17, 2022 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Mar 30, 2021 | |||||||
| Sep 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||
| Jun 30, 2015 | |||||||
| Mar 31, 2015 | |||||||
| Dec 31, 2014 |